PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1304641
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1304641
Control release drug delivery Market size was valued at USD 52,001.7 Million in 2022, expanding at a CAGR of 10.8% from 2023 to 2030.
Controlled-release drug delivery is used as a dosage form that transfers a medication or drug in a predetermined manner. Additionally, a drug delivery system offers regular delivery of medication or drugs in predictable kinetics in the whole course of gastrointestinal transit for the predetermined time. Moreover, the drug is released until it reaches a particular target in the GI tract. Further, systems of control release drug delivery use drug encapsulating devices from which the medication or drug is released at a rate that is managed for a noticeably long period, ranging from days to months.
Among these age groups, non-adherence to the medicine regimen is very common. In addition, geriatric populations undergo compromised physical, biological, and mental functions that affect their medicine intake. Moreover, their body cannot tolerate the harsh side-effects of drugs and high doses. This, in turn, increases the demand for controlled-release drug delivery systems with a steeply rising patient population. However, strict government regulations and complicated manufacturing procedures are prime factors that are expected to slow down the market growth of controlled-release drug delivery. Furthermore, lower dose requirements, improved drug efficacy and safety, minimum side effects, and improved stability of the drug are such advantages of control release drug delivery which further projected to drive market growth.
The global control release drug delivery market is segmented on the basis of technology, release mechanism, technology, and region.
The market is divided into six categories based on technology: transdermal, wurster technique, coacervation, implants, targeted delivery, microencapsulation, and others. The targeted delivery segment is likely to hold the largest revenue share. The segment demand is increasing due to the rising demand along with the increasing geriatric and pediatric population. Additionally, targeted delivery provides the site of action and can aid in allowing drugs to be away from sites that might lead to drug toxicity, as compared to traditional delivery systems.
The market is divided into five categories based on release mechanism: micro reservoir partition controlled drug delivery systems, chemically activated, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and polymer-based systems. The feedback-regulated drug delivery system is likely to possess the market share owing to therapeutic efficiency in the treatment of disorders including diabetes. Moreover, increasing R&D activities to take benefit of the potential of feedback-regulated controlled drug delivery systems as countermeasures will support market expansion.
The market is divided into six categories based on application: infusion pumps, metered dose inhalers, transdermal & ocular patches, oral controlled-drug delivery systems, inject able, and drug-eluting stents. The oral controlled segment is likely to maintain its dominance during the forecast period owing to its frequent availability and usage. Further, another lucrative segment that is expected to grow during the forecast period is metered dosage inhalers. The increasing prevalence of respiratory disorders, technological advancements, and frequent products are the major factors expected to drive the growth of the segment.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
A wide range of technologies is used by many companies that ensure controlled release. In implementing controlled release major pharmaceutical companies are also indulged to increase product penetration and consumer base. Thus, the market consists of various players from other players and new entrants facing intense competition. Moreover, key participants are indulged in R&D activities, collaboration, mergers & acquisitions, and partnerships to expand their existing product portfolios. For instance, in March 2022, Evonik announced, a new micro particle technology EUDRATEC® SoluFlow in oral drug products to develop the solubility of active pharmaceutical ingredients. Additionally, EUDRATEC SoluFlow makes it possible to develop new oral therapeutics for a variety of conditions, such as cancer, cardiovascular diseases, diabetes, and infectious diseases since more than 70 percent of new small molecules are insoluble.
For instance, in January 2021, TAPEMARK AND BIOTTS PARTNER to create MACROPERM™ for large-molecule transdermal drug delivery. Additionally, it is a new large-molecule transdermal technology that is designed to transport API (Active Pharmaceutical Ingredients) through the skin.
This proposed research study on control release drug delivery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
The report provides the client the latest up-to-date and trending insights about the control release drug delivery market.
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for control release drug delivery market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the control release drug delivery market.
Impact of COVID-19 on control release drug delivery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on control release drug delivery market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the control release drug delivery market, we have also included competitive landscape and key innovator analysis for the control release drug delivery market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the control release drug delivery market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global control release drug delivery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
The scope of this report covers the market by its major segments, which include as follows: